In this paper we review the molecular basis of the marked heterogeneit
y of the thalassemia syndromes as well as the relative implications fo
r carrier screening and prenatal diagnosis. The classical phenotype of
heterozygous beta-thalassemia may be modified by a number of environm
ental and genetic interacting factors-among which the most relevant ar
e: (1) coinheritance of alpha-thalassemia, which may normalize the red
blood cell indices; (2) the presence of a mild beta-thalassemia mutat
ion; (3) cotrasmission of delta-thalassemia which may reduce the incre
ase of HbA2 typical of heterozygous beta-thalassemia to normal values
and (4) the presence of a silent mutation which can be defined only by
imbalanced beta-globin chain synthesis. A number of molecular mechani
sms are able to produce the non transfusion dependent attenuated forms
of thalassemia syndromes referred to as thalassemia intermedia. The m
ost common are homozygosity for mild beta-thalassemia mutations, coinh
eritance with homozygous beta-thalassemia of alpha-thalassemia or gene
tic determinants able to substain a continuous production of HbF in ad
ult life or the presence of heterozygosity for hyperunstable globin va
riants.